Study of the increased efficacy of heparin due to carbenicillin
Wamhoff, D.
Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 30(20): 687-689
1975
ISSN/ISBN: 0044-2542 PMID: 1216951 Document Number: 85933
On 15 patients in the in-vitro-experiment the effect of carbenicillin on the collagen-induced aggregation of platelets and the release of the platelet factor 4 neutralising heparin is examined. In a high dosage carbenicillin leads to an inhibition of these platelet functions. Therefore, a combination of carbenicillin with heparin may cause an increased readiness for haemorrhage for the patient.
Document emailed within 1 workday
Related Documents
Rychkova, M.A.; Kiniaikin, M.F.; Przheborovskaia, N.S. 1983: Comparative evaluation of the efficacy of electrophoresis of heparin and heparin combined with fibrinolysin in protracted pneumonias Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 18-21Grunebaum, L.; Fricker, J.P.; Wiesel, M.L.; Vergnes, Y.; Kapps, J.; Cazenave, J.P. 1987: Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery Journal des Maladies Vasculaires 12 Suppl B: 102-104
Willital, G.ün.H.; Simon, J. 2013: Efficacy of early initiation of a gel containing extractum cepae, heparin, and allantoin for scar treatment: an observational, noninterventional study of daily practice Journal of Drugs in Dermatology: Jdd 12(1): 38-42
Heit, J.A.; Berkowitz, S.D.; Bona, R.; Cabanas, V.; Corson, J.D.; Elliott, C.G.; Lyons, R. 1997: Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group Thrombosis and Haemostasis 77(1): 32-38
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Venakatachalapathy, T.S.; Mohan Kumar, S.; Saliba, M.J. 2007: A comparative study of burns treated with topical heparin and without heparin Annals of Burns and Fire Disasters 20(4): 189-198
Chiu, H.M.; van Aken, W.G.; Hirsh, J.; Regoeczi, E.; Horner, A.A. 1977: Increased heparin clearance in experimental pulmonary embolism Journal of Laboratory and Clinical Medicine 90(1): 204-215
Pelayo Alonso, R.; Cobo Sánchez, J.L.; de Buruaga Perea, A.S.áe.; Menezo Viadero, R.; Gándara Revuelta, M.; Aja Crespo, A.; Tovar Rincón, A. 2013: Comparative study between 20 IU/ml heparin and 5% heparin/urokinase 5000 IU lock in hemodialysis central venous catheters with permeability problems Revista de Enfermeria 36(3): 8-12
Mackie, I.J.; Segal, H.; Burren, T.; Gallimore, M.; Walshe, K.J.; Robinson, G.; Machin, S.J. 1990: Heparin cofactor Ii levels are increased by the use of combined oral contraceptives Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 1(6): 647-651
Gärdlund, B. 1996: Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group Lancet 347(9012): 1357-1361
Goldberg, G.A.; Suriadnova, B.A.; Stepanov, M.A.; Kochanko, E.P. 1972: A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin Cor et Vasa 14(2): 81-95
Hortin, G.L.; Cole, T.G.; Gibson, D.W.; Kessler, G. 1988: Decreased stability of triglycerides and increased free glycerol in serum from heparin-treated patients Clinical Chemistry 34(9): 1847-1849
Møller, N.E.; Eriksen, K.R.; Feddersen, C.; Flensborg, E.W.; Høiby, N.; Norn, S.; Rosendal, K.; Schiøtz, P.O.; Skov, P.S. 1982: Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. a study of carbenicillin, azlocillin or piperacillin in combination with tobramycin European Journal of Respiratory Diseases 63(2): 130-139
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Petitou, M.; Lormeau, J.C.; Choay, J. 1991: A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin IIi Seminars in Thrombosis and Hemostasis 17(Suppl 2): 143-146
Shestakova, M.V.; Chugunova, L.A.; Vorontsov, A.V.; Dedov, I.I. 1997: The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy Terapevticheskii Arkhiv 69(6): 34-37
Alkhunaizi, A.M.; Olyaei, A.J.; Barry, J.M.; deMattos, A.M.; Conlin, M.J.; Lemmers, M.J.; Bennett, W.M.; Norman, D.J. 1998: Efficacy and safety of low molecular weight heparin in renal transplantation Transplantation 66(4): 533-534
Pyrih, L.A.; Lapchyns'ka, I.I.; Dorets'kyĭ, V.V. 1993: A retrospective analysis of the efficacy of the heparin therapy of glomerulonephritis patients Likars'ka Sprava 1993(7): 84-88
Patrassi, G.M.; Toffanin, F.; Massa, G.; Schivazappa, L.; Girolami, A. 1979: Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state Folia Haematologica 106(3): 414-425
Burg, M.; Ostendorf, T.; Mooney, A.; Koch, K.M.; Floege, J. 1997: Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety Laboratory Investigation; A Journal of Technical Methods and Pathology 76(4): 505-516